The relationship between micronutrient status, supplementation, and cancer outcomes is one of the most actively studied — and nuanced — areas of oncology nutrition. While no supplement is a cancer treatment, a growing body of research suggests that specific nutrient insufficiencies may affect tumor progression, treatment tolerability, immune function, and survivorship quality of life in meaningful ways.
Important Context: Supplements Are Not Cancer Treatments
It is critical to state clearly at the outset: no vitamin or supplement has been proven to treat or cure cancer. Framing supplementation in the context of cancer must be done carefully and with respect for the complexity of oncological treatment. Nutritional support during and after cancer treatment is best understood as supportive care — addressing documented deficiencies, supporting immune function, reducing treatment side effects, and promoting overall resilience — not as alternative or curative therapy. All supplementation decisions for cancer patients should be made with their oncologist and a registered dietitian specializing in oncology nutrition.
Areas of Active Research
Vitamin D: Multiple epidemiological studies have found associations between higher serum 25(OH)D levels and improved outcomes in several cancers, including colorectal, breast, and prostate cancer. The VITAL trial (a large RCT) found a 17% reduction in cancer mortality in the vitamin D supplementation arm, particularly in those at healthy weight. A Japanese RCT published in BMJ found that vitamin D3 supplementation (2,000 IU/day) was associated with a significant reduction in the risk of relapse or death in patients with digestive tract cancers. Vitamin D deficiency is extremely common in cancer patients and associated with poorer treatment tolerance.
Omega-3 fatty acids: Research suggests omega-3 supplementation during chemotherapy may reduce inflammation, support immune function, preserve muscle mass (sarcopenia is a significant concern in cancer patients), and potentially improve chemotherapy response in certain settings. The anti-inflammatory and pro-resolving properties of EPA and DHA may help modulate the tumor microenvironment's inflammatory signaling.
Selenium: Selenium is essential for glutathione peroxidase function and thyroid hormone metabolism. Low selenium status is associated with higher cancer incidence in multiple epidemiological studies. While high-dose selenium supplementation as cancer prevention has not been consistently supported (the SELECT trial found no benefit of selenium for prostate cancer), correcting deficiency is clinically important.
Melatonin: Several randomized trials — primarily conducted in Italian research centers — have found that melatonin supplementation (10–20 mg/day) alongside chemotherapy was associated with improved one-year survival rates and reduced chemotherapy toxicity (myelosuppression, neuropathy) in patients with advanced solid tumors. These findings remain preliminary and require replication in larger trials.
Antioxidants during chemotherapy — an important caution: The use of antioxidant supplements (high-dose vitamins C, E, selenium) during active chemotherapy or radiation is controversial. The concern is that antioxidants may theoretically protect cancer cells from oxidative damage — the mechanism by which many treatments work. Current evidence is mixed, and this decision must always involve the oncologist.
How APF Approaches Oncology Nutrition Support
Advance provides foundational micronutrient formulations — vitamin D3, omega-3, magnesium — manufactured in a triple-certified facility (UL, NSF, SQF) with third-party testing for purity and accurate dosing. We do not make cancer treatment claims. These products are supportive nutritional tools for those working with their oncology team to address documented deficiencies.
How to Use
Cancer patients should always discuss supplementation with their oncologist before starting anything new — timing relative to treatment cycles, potential interactions, and individual nutritional status all matter. A registered oncology dietitian can assess your specific nutritional needs and guide a personalized supplementation plan.
Why Professional-Grade?
In the context of cancer survivorship, supplement quality and accuracy are not optional. APF's triple-certified, third-party tested formulations give oncology patients and their care teams confidence in exactly what they're administering.
Explore APF's foundational supplement range at and work with your oncology team to build a comprehensive nutritional support plan.
